NAA10 Antibody
Product Specifications
Background
N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes an N-terminal acetyltransferase that functions as the catalytic subunit of the major amino-terminal acetyltransferase A complex. Mutations in this gene are the cause of Ogden syndrome. Alternate splicing results in multiple transcript variants.
NCBI Gene ID
8260
Swiss Prot
P41227
Host
Rabbit
Reactivity
Human, Mouse, Rat
Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 161-235 of human NAA10 (NP_003482.1) .
Clonality
Polyclonal
Conjugation
Unconjugated
Type
Primary Antibodies
Field of Research
Signal Transduction
Purification
Affinity purification
Positive Control
MCF7
Concentration
Batch dependent
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Store at -20˚ C. Avoid freeze / thaw cycles.
Calculated Molecular Weight
Observed: 26kDa
Fragment
IgG
Symbol
NAA10
Positive Control 2
HeLa
Positive Control 3
HL-60
Positive Control 4
HepG2
Positive Control 5
HT-29
Positive Control 6
Mouse thymus
NCBI Official Name
N (alpha) -acetyltransferase 10, NatA catalytic subunit
NCBI Organism
Homo sapiens
Other Product Names
ARD1A, ARD1, DXS707, MGC71248, TE2, NATD, ARD1A, ARD1P, MCOPS1
Tested Applications
WB, IHC, IF
Physical Properties
Liquid
More Discoveries
Explore Other Products
Browse additional items from our catalog
